Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(6): e0129776, 2015.
Article in English | MEDLINE | ID: mdl-26075887

ABSTRACT

PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization and trafficking of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked PICALM Single Nucleotide Polymorphisms (SNPs) to Alzheimer's disease. To obtain insight into the biological role of PICALM, we performed gene expression studies of PICALM-deficient and PICALM-expressing cells. Pathway analysis demonstrated that PICALM expression influences the expression of genes that encode proteins involved in cholesterol biosynthesis and lipoprotein uptake. Gas Chromatography-Mass Spectrometry (GC-MS) studies indicated that loss of PICALM increases cellular cholesterol pool size. Isotopic labeling studies revealed that loss of PICALM alters increased net scavenging of cholesterol. Flow cytometry analyses confirmed that internalization of the LDL receptor is enhanced in PICALM-deficient cells as a result of higher levels of LDLR expression. These findings suggest that PICALM is required for cellular cholesterol homeostasis and point to a novel mechanism by which PICALM alterations may contribute to disease.


Subject(s)
Cholesterol/metabolism , Homeostasis , Monomeric Clathrin Assembly Proteins/metabolism , Animals , Biosynthetic Pathways/genetics , Cell Line , Gene Expression , Gene Knockout Techniques , Humans , Mice , Monomeric Clathrin Assembly Proteins/genetics , Organ Specificity , Protein Transport , RNA Interference , RNA, Small Interfering/genetics , Receptors, LDL/metabolism
2.
Nat Commun ; 5: 4998, 2014 Sep 22.
Article in English | MEDLINE | ID: mdl-25241929

ABSTRACT

Genome-wide association studies have identified several loci associated with Alzheimer's disease (AD), including proteins involved in endocytic trafficking such as PICALM/CALM (phosphatidylinositol binding clathrin assembly protein). It is unclear how these loci may contribute to AD pathology. Here we show that CALM modulates autophagy and alters clearance of tau, a protein which is a known autophagy substrate and which is causatively linked to AD, both in vitro and in vivo. Furthermore, altered CALM expression exacerbates tau-mediated toxicity in zebrafish transgenic models. CALM influences autophagy by regulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have diverse effects on different stages of the autophagy pathway, from autophagosome formation to autophagosome degradation. This study suggests that the AD genetic risk factor CALM modulates autophagy, and this may affect disease in a number of ways including modulation of tau turnover.


Subject(s)
Autophagy , Monomeric Clathrin Assembly Proteins/metabolism , tau Proteins/metabolism , Animals , Autophagy-Related Protein 12 , Cell Line , Drosophila , Endocytosis , Female , Fibroblasts/metabolism , Genome-Wide Association Study , HEK293 Cells , HeLa Cells , Humans , Male , Mice , Phagosomes , Protein Binding , RNA, Small Interfering/metabolism , Risk Factors , Small Ubiquitin-Related Modifier Proteins/metabolism , Transfection , Vesicle-Associated Membrane Protein 2/metabolism , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...